Abstract
BackgroundNitisinone has transformed the management of hereditary tyrosinaemia type 1 (HT1). However, the risk of developing hepatocellular carcinoma is related to the age at which treatment is commenced. Little data...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have